XML 52 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock options valuation assumptions

    

2021

    

2020

Fair value of common stock

$8.80 – $21.29

$3.41 – $6.59

Expected term (years)

5.1 – 7.0

5.0 – 6.2

Expected volatility

40.0% – 41.4%

37.0% – 41.7%

Risk-free interest rate

0.7% –1.3%

0.3% – 0.8%

Expected dividend yield

0.0%

0.0%

Schedule of unvested stock options activity

    

Number of 

    

Carrying 

Shares

Value

Unvested as of December 31, 2019

 

86,032

$

115

Exercised

 

1,375

$

2

Repurchased

 

(42,073)

$

(49)

Vested

 

(24,394)

$

(32)

Unvested as of December 31, 2020

 

20,940

$

36

Exercised

 

463,816

$

917

Repurchased

 

(13,876)

$

(23)

Vested

 

(88,841)

$

(145)

Unvested as of December 31, 2021

 

382,039

$

785

Restricted Stock Awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of unvested stock options activity

Weighted-

average

Number of 

Grant Date

    

Shares

    

Fair Value

Unvested balance as of December 31, 2019.

 

1,940,130

$

1.21

Granted

 

$

Vested

 

(541,704)

$

1.69

Cancelled/Forfeited

 

$

Unvested balance as of December 31, 2020.

 

1,398,426

$

1.02

Granted

 

$

Vested

 

(500,000)

$

1.78

Cancelled/Forfeited

 

$

Unvested balance as of December 31, 2021

 

898,426

$

0.60

Stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock option activity

Weighted-

Aggregate

Weighted average

averages

Intrinsic

    

Stock Options

    

Exercise Price

    

Life (Years)

    

Value

Balance as of December 31, 2019

 

1,081,579

$

2.31

 

8.9

$

2,817

Granted

 

3,251,443

$

2.60

 

 

  

Exercised

 

(307,778)

$

1.56

Cancelled/Forfeited/Expired

 

(816,181)

$

2.03

 

  

Balance as of December 31, 2020

 

3,209,063

$

1.57

9.1

$

16,094

Granted

 

3,457,020

$

9.37

 

  

Exercised

 

(1,247,236)

$

1.68

Cancelled/Forfeited/Expired

 

(387,537)

$

2.00

 

  

Balance as of December 31, 2021

 

5,031,310

$

6.85

9.2

$

120,491

Vested and exercisable as of December 31, 2021

 

1,284,624

$

2.33

8.3

$

36,579

Schedule of stock options valuation assumptions

Fair value of common stock

$

19.07

 

Expected term (years)

 

5.3

Expected volatility

 

40.0

%

Risk-free interest rate.

 

0.7

%

Expected dividend yield

 

0.0

%